Abstract
Involvement of the central nervous system (CNS) contributes substantially to morbidity and mortality of vertical infection with the hu man immunodeficiency virus (HIV) 1. The clinical spectrum ranges from minor developmental disabilities to severe and progressive encephalopathy. Progression of the disease varies considerably. Both direct viral and indirect host-related pathogenic mechanisms have been proposed. The diagnosis depends on neurological and neurodevelopmental assessments. So far, HIV-1-specific antiviral treatment has shown limited effects on neurological manifestations in symptomatic children. Thus, efforts are needed to improve prevention and treatment of CNS involvement. It is still unclear whether early use of antiretroviral agents is of benefit.
Similar content being viewed by others
Abbreviations
- ADC :
-
AIDS dementia complex
- AIDS :
-
acquired immunodeficiency syndrome
- AZT :
-
azidothymidine; zidovudine
- ddC :
-
dideoxycytidine; zalcitabine
- ddI :
-
dideoxyinosine; didanosine
- d4T :
-
stavudine HIV-1 human immunodeficiency virus type 1
- PE :
-
HIV-1-related progressive encephalopathy of childhood
- PET :
-
positron emission tomography
- PMRS :
-
proton magnetic resonance spectroscopy
- SPECT :
-
single photon emission computed tomography
- 3TC :
-
lamivudine
References
Anand A, Carmosino L, Glatt AE (1993) Management of recalcitrant pain in a paediatric acquired immunodeficiency syndrome patient. Pediatr Infect Dis J 12:159–160
Atwood WJ, Berger JR, Kaderman R, Tornatore CS, Major EO (1993) Human immunodeficiency virus type 1 infection of the brain. Clin Microbiol Rev 6:339–366
Balis FM, Pizzo PA, Eddy J, Wilfert C, McKinney R, Scott G, Murphy RF, Jarosinski PF, Falloon J, Poplack DG (1989) Pharmakokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection. J Pediatr 114:880–884
Balis FM, Pizzo PA, Butler KM, Hawkins ME, Brouwers P, Husson RN, Jacobsen F, Blaney SM, Gress J, Jarosinski P, Poplack DG (1992) Clinical pharmacology of 2′,3′-dideoxyinosine in human immunodeficiency virus-infected children. J Infect Dis 165:99–104
Belman AL, Ultman MH, Horoupian D, Novick B, Spiro AJ, Rubinstein A, Kurtzberg D, Cone-Wesson B (1985) Neurologicalal complications in in fants and children with acquired immune deficiency syndrome. Ann Neurol 18:560–566
Belman AL, Lantos G, Horoupian D, Novick BE, Ultmann MH, Dickson DW, Rubinstein A (1986) AIDS: calcifications of the basal ganglia in infants and children. Neurology 36: 1192–1199
Belman AL, Diamond G, Dickson D, Horoupian D, Llena J, Lantos G, Rubinstein A (1988) Paediatric acquired immunodeficiency syndrome. Neurological syndromes. Am J Dis Child 142:29–35
Berger JR, Scott G, Albrecht J, Belman AL, Tornatore C, Major EO (1992) Progressive multifocal leukoencephalopathy in HIV-1-infected children. AIDS 6:837–841
Blanche S, Caniglia M, Fischer A, Rouzioux C, Burgard M, Tardieu M, Duhamel G, Griscelli C (1988) Zidovudine therapy in children with acquired immunodeficiency syndrome. Am J Med 85:203–207
Blanche S, Rouzioux C, Guihard Moscato M-L, Veber F, Mayaux M-J, Jacomet C, Tricoire C, Deville A, Vial M, Firtion G, de Crepy A, Douard D, Robin M, Courpotin C, Ciraru-Vigneron N, le Deist F, Griscelli C, HIV infection in Newborns French Collaborative Study Group (1989) A prospective study of infants born to women seropositive for human immunodeficiency virus type I. N Engl J Med 320:1643–1648
Blanche S, Tardieu M, Rouzioux C, Le Deist F, Fukunaga K, Caniglia M, Jacomet C, Messiah A, Griscelli C (1990) Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Am J Dis Child 144:1210–1215
Blanche S, Duliege A-M, Navarette MS, Tardieu M, Debré M, Rouzioux C, Seldrup J, Kouzan S, Griscelli C (1991) Low-dose zidovudine in children with an human immunodeficiency virus type 1 infection acquired in the perinatal period. Paediatrics 88:364–370
Blanche S, Calvez T, Rouzioux C, Ortigao MB, Taburet AM, Ferroni A, Debre M, Wintrebert F, Singlas E, Costagliola D, Griscelli C (1993) Randomized study of two doses of didanosine in children infected with human immunodeficiency virus. J Pediatr 122:966–973
Blanche S, Mayaux M-J, Rouzioux C, Teglas J-P, Firtion G, Monpoux F, Ciraru-Vigneron N, Meier F, Tricoire J, Courpotin C, Vilmer E, Griscelli C, Delfraissy J-F, The French Paediatric HIV Infection Study Group (1994) Relation of the course of HIV infection in children to the severity of the disease in the mothers at delivery. N Engl J Med 330:308–312
Blumberg BM, Gelbard HA, Epstein LG (1994) HIVA infection of the developing nervous system: central role of astrocytes in pathogenesis. Virus Research 32:253–267
Boucher FD, Modlin JF, Weller S, Ruff A, Mirochnik M, Pelton S, Wilfert C, McKinney R, Crain MJ, Elkins MM, Blim R, Prober CG (1993) Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus. J Pediatr 122:137–144
Brinkmann R, Schwinn A, Narayan O, Zink C, Kreth HW, Roggendorf W, Dörries R, Schwender S, Imrich H, Meulen V ter (1992) Human immunodeficiency virus infection in mi croglia: correlation between cells infected in the brain and cells cultured from infectious brain tissue. Ann Neurol 31:361–365
Brouwers P, Moss H, Wolters P, Eddy J, Balis F, Poplack DG, Pizzo PA (1990) Effect of continuous-infusion zidovudine therapy on neuropsychologic functioning in children with symptomatic human immunodeficiency virus infection. J Pediatr 117: 980–985
Brivio L, Tornaghi R, Musetti L, Marchisio P, Principi N (1991) Improvement of auditory brainstem responses after treatment with zidovudine in a child with AIDS. Pediatr Neurol 7:53–55
Brouwers P, Belman AL, Epstein LG (1993) Central nervous system involvement: manifestations and evaluation. In: Pizzo PA, Wilfert CM, (eds) Paediatric AIDS. 2nd edn. Williams and Wilkins, Baltimore, pp 433–455
Brouwers P, Heyes MP, Moss HA, Wolters PL, Poplack DG, Markey SP, Pizzo PA (1993) Quinolonic acid in the cerebrospinal fluid of children with symptomatic human immunodeficiency virus type 1 disease: relationships to clinical status and therapeutic response. J Infect Dis 168:1380–1386
Brouwers P, DeCarli C, Tudor-Williams G, Civitello L, Moss H, Pizzo P (1994) Interrelations among patterns of change in neurocognitive, CT brain imaging and CD4 measures associated with anti-retroviral therapy in children with symptomatic HIV infection. Adv Neuroimmunol 4:223–231
Brouwers P, DeCarli C, Civitello L, Moss H, Wolters P, Pizzo P (1995) Correlation between computed tomographic brain scan abnormalities and neuropsychological function in children with symptomatic human immunodeficiency virus disease. Arch Neurol 52:39–44
Brouwers P, Tudor-Williams G, DeCarli C, Moss HA, Wolters PL, Civitello LA, Pizzo PA (1995) Relation between stage of disease and neurobehavioral measures in children with symptomatic HIV disease. AIDS 9:713–720
Brüstle O, Spiegel H, Leib SL, Finn T, Stein H, Kleihues P, Wiestler OD (1992) Distribution of human immunodeficiency virus (HIV) in the CNS of children with severe HIV encephalomyelopathy. Acta Neuropathol 84:24–31
Brunetti A, Berg G, DiChiro G, Cohen RM, Yarchoan R, Pizzo PA, Broder S, Eddy J, Fulham MJ, Finn RD, et al (1989) Reversal of brain metabolic abnormalities following treatment of AIDS dementia complex with 3′-azido-2′,3′ dideoxythymidine: a PET-FDG study. J Nucl Med 30:581–590
Butler C, Hittelman J, Hanger SB (1991) Approach to neurodevelopmental and neurological complications in paediatric HIV infection. J Pediatr 119:S41-S46
Butler KM, Husson RN, Balis FM, Brouwers P, Eddy J, El-Amin D, Gress J, Hawkins M, Jarosinski P, Moss H, Poplack D, Santacroce S, Venzon D, Wiener L, Wolters P, Pizzo PA (1991) Dideoxyinosinein children with symptomatic human immunodeficiency virus infection. N Engl J Med 324:137–144
Caldwell MB, Oxtoby MJ, Simonds MJ, Lindegren ML, Rogers MF (1994) 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 43:1–19
Chamberlain MC (1993) Paediatric AIDS: a longitudinal comparative MRI and CT brain imaging study. J Child Neurol 8:175–181
Chamberlain MC, Nichols SL, Chase CH (1992) Paediatric AIDS: comparative cranial MRI and CT scans. Pediatr Neurol 7:357–362
Chase C, Vibbert M, Pelton SI, Coulter DL, Cabral H (1995) Early neurodevelopmental growth in children with vertically transmitted human immunodeficiency virus infection. Arch Pediatr Adolesc Med 149:850–855
Chiodi F, Fenyö EM (1991) Neurotropism of human immunodeficiency virus. Brain Pathol 1:185–191
Civitello LA (1991) Neurological complications of HIV infection in children. Pediatr Neurosurg 17:104–112
Condini A, Axia G, Cattelan C, D'Urso MR, Laverda AM, Viero F, Zacchello F (1991) Development of language in 18-30-month-old HIV-infected but not ill children. AIDS 5:735–739
Cornaglia-Ferraris P, De Maria A, Cirillo C, Cara A, Alessandri G (1995) Adhesion of human neuroblasts to HIV-1 tat. Pediatr Res 38:792–796
Coney A, Jarvik JG, Lenkinski RE, Grossman RI, Frank I, Delivoria-Papadopoulos M (1994) Proton MR spectroscopy of brain abnormalities in neonates born to HIV-positive mothers. AJNR 15:1853–1859
Current Trends (1987) Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age. MMWR 36:225–230, 235–236
Davis SL, Halsted CC, Levy N, Ellis W (1987) Acquired immunodeficiency syndrome presenting as progressive infantile encephalopathy. JPediatr 110:884–888
DeCarli C, Fugate L, Falloon J, Eddy J, Katz DA, Friedland RP, Rapoport SI, Brouwers P, Pizzo PA (1991) Brain growth and cognitive improvement in children with human immunodeficiency virus-induced encephalopathy after 6 months of continuous infusion zidovudine therapy. J AIDS 4:585–592
DeCarli C, Civitello LA, Brouwers P, Pizzo PA (1993) The prevalence of computed tomographic abnormalities of the cerebrum in 100 consecutive children symptomatic with the human immune deficiency virus. Ann Neurol 34:198–205
Depas G, Chiron C, Tardieu M, Nuttin C, Blanche S, Raynaud C, Syrota A (1995) Functional brain imaging in HIV-1-infected children born to seropositive mothers. J Nucl Med 36:2169–2174
Diamond GW (1989) Developmental problems in children with HIV infection. Ment Retard 27:213–217
Dickson DW, Belman AL, Horoupian DS, Rubinstein A (1989) Spinal cord pathology in paediatric acquired immunodeficiency syndrome. Neurology 39:227–235
Ensoli F, Cafaro A, Morelli V, Vannelli B, Ensoli B, Thiele CJ (1995) HIV-1 infection of primary human neuroblasts. Virology 210:221–225
Epstein LG, Gendelman HE (1993) Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Ann Neurol 33:429–436
Epstein LG, Sharer LR, Joshi VV, Fojas MM, Koenigsberger MR, Oleske JM (1985) Progressive encephalopathy in children with acquired immune deficiency syndrome. Ann Neurol 17:488–496
Epstein LG, Sharer LR, Oleske JM, Connor EM, Goudsmit J, Bagdon L, Robert-Guroff M, Königsberger MR (1986) Neurological manifestations of human immunodeficiency virus infection in children. Paediatrics 78:678–687
Epstein LG, Berman CZ, Sharer LR, Khademi M, Desposito F (1987) Unilateral calcification and contrast enhancement of the basal ganglia in a child with AIDS encephalopathy. AJNR 8:163–165
Epstein LG, Goudsmit J, Paul DA, Morrison SH, Connor EM, Oleske JM, Holland B (1987) Expression of human immunodeficiency virus in cerebrospinal fluid of children with progressive encephalopathy. Ann Neurol 21:397–401
Epstein LG, Sharer LR, Goudsmit J (1988) Neurologicalal and neuropathological features of human immunodeficiency virus infection in children. Ann Neurol 23:519–523
European Collaborative Study (1991) Children born to women with HIV-1 infection: natural history and risk of transmission. Lancet 337:253–260
Falangola MF, Hanly A, Galvao-Castro B, Petito CK (1995) HIV infection of human choroid plexus: a possible mechanism of viral entry into the CNS. J Neuropathol Exp Neurol 54:497–503
Galli L, Martiono M de, Tovo P-A, Gabiano C, Zappa M, Giaquinto C, Tulisso S, Vierucci A, Guerra M, Marchision P, Plebani A, Zuccotti GV, Martino AM, Dallacasa P, Stegnano M, Italian Register for HIV Infection in Children (1995) Onset of clinical signs in children with HIV-1 perinatal infection. AIDS 9:455–461
Gallo P, Laverda AM, DeRossi A, Pagni S, Del Mistro A, Cogo P, Piccinno MG, Plebani A, Tavolato B, Chieco-Bianchi L (1991) Immunological markers in the cerebrospinal fluid of HIV-1-infected children. Acta Paediatr Scand 80:659–666
Gallo P, De Rossi A, Sivieri S, Chieco-Bianchi L, Tavolato B (1994) M-CSF production by HIV-1-infected monocytes and its intrathecal synthesis. Implications for neurologicalal HIV-related disease. J Neuroimmunol 51:193–198
Garcia Rodriguez MC, Omenaca F, Ferreira A, Madero R, Zapico R, Muro M, De Jose I, Fontan G (1991) Immunological follow-up in children born to HIV-1 infected mothers. Acta Paediatr Scand 80:1183–1191
Gartner S, Markovits P, Markovits DM, Betts RF, Popovic M (1986) Virus isolation from and identification of HTLV-III/LAV producing cells in brain tissue from a patient with AIDS. JAMA 256:2365–2372
Gay CL, Armstrong FD, Cohen D, Lai S, Hardy MD, Swales TP, Morrow CJ, Scott GB (1995) The effects of HIV on cognitive function and motor development in children born to HIV-seropositive women with no reported drug use: birth to 24 months. Paediatrics 96:1078–1082
Gibb D, Barry M, Ormesher S, Nokes L, Seefried M, Giaquinto C, Back D (1995) Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in children with HIV infection. Br J Clin Pharmacol 39:527–530
Goudsmit J, Wolf F de, Paul DA, Epstein LG, Lange JMA, Krone WJA, Speelman H, Wolters EC, Van Der Noordaa J, Oleske JM, Van Der Helm H, Coutinho RA (1986) Expression o human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet 11:177–180
Grubman S, Simonds RJ (1996) Preventing Pneumocystis carinii pneumonia in human immunodeficiency virus-infected children: new guidelines for prophylaxis. Pediatr Infect Dis J 15:165–168
Habibi P, Strobel S, Smith I, Hyland K, Howells DW, Holzel H, Brett EM, Wilson J, Morgan G, Levinsky RJ (1989) Neurodevelopmental delay and focal seizures as presenting symptoms of human immunodeficiency virus I infection. Eur J Pediatr 148:315–317
Hatch WC, Pousada E, Losev L, Rashbaum WK, Lyman WD (1994) Neural cell targets of human immunodeficiency virus type 1 in human fetal organotypic cultures. AIDS Res Hum Retroviruses 10:1597–1607
Heindel WC, Jernigan TL, Archibald SL, Achim CL, Masliah E, Wiley CA (1994) The relationship of quantitative brain magnetic resonance imaging measures to neuropathologic indexes of human immunodeficiency virus infection. Ann Neurol 51:1129–1135
Ho DD, Rota TR, Schooley RT, Kaplan JC, Allan JD, Groopman JE, Resnick L, Felsenstein D, Andrews CA, Hirsch MS (1985) Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurological syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 313:1493–1497
olman BL, Johnson KA (1991) HIV encephalopathy: on the road to a useful diagnostic test? J Nucl Med 32:1475–1477
Husson RN, Pizzo PA (1992) The use of nucleoside analogues in the treatment of HIV-infected children. AIDS Res Hum Retroviruses 8:1059–1064
Husson RN, Chung Y, Mordenti J, Butler KM, Chen S, Duliege A-M, Brouwers P, Jarosinski P, Mueller BU, Ammann A, Pizzo PA (1992) Phase I study of continuous-infusion soluble CD4 as a single agent and in combination with oral dideoxyinosine therapy in children with symptomatic human immunodeficiency virus infection. J Pediatr 121:627–633
Husson R, Saini R, Lewis LL, Butler KM, Patronas N, Pizzo PA (1992) Cerebral artery aneurysms in children infected with human immunodeficiency virus. J Pediatr 121:927–930
Husson RN, Mueller BU, Farley M, Woods L, Kovacs A, Goldsmith JC, Ono J, Lewis LL, Balis FM, Brouwers P, Avramis VI, Church JA, Butler KM, Rasheed S, Jarosinski P, Venzon D, Pizzo PA (1994) Zidovudine and didanosine combination therapy in children with human immunodeficiency virus infection. Paediatrics 93:316–322
Italian Register for HIV Infection in Children (1994) Features of children perinatally infected with HIV-1 surviving longer than 5 years. Lancet 343:191–195
Kauffman WM, Sivit CJ, Fitz CR, Rakusan TA, Herzog K, Chandra RS (1992) CT and MR evaluation of intracranial involvement in paediatric HIV infection: a clinical-imaging correlation. AJNR 13:949–957
Kind C (1994) HIV-Uebertragung von der Mutter auf das Kind. Hans Huber, Bern, 102
Kline MW, Dunkle LM, Church JA, Goldsmith JC, Harris AT, Federici ME, Schultze ME, Woods L, Loewen DF, Kaul S, Cross A, Rutkiewicz VL, Rosenblatt HM, Hanson IC, Shearer WT (1995) A phase I/II evaluation of stavudine (d4T) in children with human immunodeficiency virus infection. Paediatrics 96:247–252
Koralnik IJ, Hirschel B (1991) Complications neurologiques de l'infection par le virus d'immunodeficience humaine. Presse Med 20:1129–1135
Koyanagi Y, Miles S, Mitsuyagu RT, Merrill JE, Vinters HV, Chen ISY (1987) Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236:819–822
Kure K, Llena JF, Lyman WD, Soiero R, Weidenheim KM, Hirano A, Dickson DW (1991) Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, paediatric, and fetal brains. Hum Pathol 22:700–710
Lacroix C, Vazeux R, Brousse N, Blanche S, Tardieu M (1993) Etude neuropathologique de 10 enfants infectés par le VIH. Rev Neurol (Paris) 149:37–45
Lang C, Jacobi G, Kreuz W, Hacker H, Herrmann G, Keul H-G, Thomas E (1992) Rapid development of giant aneurysm at the base of the brain in an 8-year-old boy with perinatal HIV infection. Acta Histochemica 42:83–90
Larder BA, Kemp SD, Harrigan PR (1995) Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy. Science 269:696–699
Levenson RL, Mellins CA, Zawadzki R, Kairam R, Stein Z (1992) Cognitive assessment of human immunodeficiency virus-exposed children. Am J Dis Child 146:1479–1483
Lipton SA, Gendelman HE (1995) Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 332:934–940
Lobato MN, Caldwell B, Ng P, Oxtoby MJ, The Paediatric Spectrum of Disease Clinical Consortium (1995) Encephalopathy in children with perinatally acquired human immunodeficiency virus infection. J Pediatr 126:710–715
Masdeu JC, Yudd A, Van Heertum RL, Grundman M, Hriso E, O'Connell RA, Luck D, Camli U, King LN (1991) Single photon emission computed tomography in human immunodeficiency virus encephalopathy: a preliminary report. J Nucl Med 32: 1471–1475
McKinney RE, Pizzo PA, Scott GB, Parks WP, Maha MA, Nusinoff-Lehrman S, Riggs M, Eddy J, Lane BA, Eppes SC, Wilfert CM, Paediatric Zidovudine Phase I Study Group (1990) Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected paediatric patients. J Pediatr 116:640–647
McKinney RE, Maha MA, Connor EM, Feinberg J, Scott GB, Wulfsohn M, McIntosh K, Borkowsky W, Modlin JF, Weintrub P, O'Donnell K, Gelber RD, Rogers GK, Nusinoff Lehrman S, Wilfert CM, Protocol 043 Study Group (1991) A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. N Engl J Med 324:1018–1025
Miles SA, Balden E, Magpantay L, Wie L, Leiblein A, Hofheinz D, Toedter G, Stiehm ER, Bryson Y (1993) Rapid serologic testing with immune-complex-dissociated HIV p24 antigen for early detection of HIV infection in neonates. N Engl J Med 328:297–302
Mintz M (1994) Clinical comparison of adult and paediatric neuroAIDS. Adv Neuroimmunol 4:207–221
Mintz M, Oleske JM, Connor EM, Koenigsberger MR, Denny T, Epstein LG (1989) Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome. Am J Dis Child 143:771–774
Mitchell WG, Nelson MD, Contant CF, Bale JF, Wilson DA, Bohan TP, Fenstermacher MJ (1993) Effects of human immunodeficiency virus and immune status on magnetic resonance imaging of the brain in hemophilic subjects: results from the hemophilia growth and development study. Paediatrics 91:742–746
Mok JQ, Giaquinto C, De Rossi A, Grosch-Wörner I, Ades AE, Peckha CS (1987) Infants born to mothers seropositive for human immunodeficiency virus. Preliminary findings from a multicenter European study. Lancet 1:1164–1168
Msellati P, Lepage P, Hitimana D-G, Van Goethem C, Van de Perre P, Dabis F (1993) Neurodevelopmental testing of children born to human immunodeficiency virus type 1 seropositive and seronegative mothers: a prospective cohort study in Kigali, Rwanda. Paediatrics 92:843–848
Mueller BU, Shad AT, Magrath IT, Horowitz ME (1993) Malignancies in children with HIV infection. In: Pizzo PA, Wilfert CA (eds) Paediatric AIDS, 2nd edn Williams and Wilkins, Baltimore pp 603–622
Mueller BU, Butler KM, Stocker VL, Balis FM, Brouwers P, Jarosinski P, Husson RN, Linda LL, Venzon D, Pizzo PA (1994) Clinical and pharmacokinetic evaluation of long-term therapy with didanosine in children with HIV infection. Paediatrics 94:724–731
Mueller BU, Pizzo PA, Farley M, Husson RN, Goldsmith J, Kovacs A, Woods L, Ono J, Church JA, Brouwers P, Jarosinski P, Venzon D, Balis FM (1994) Pharmacokinetic evaluation on the combination of zidovudine and didanosine in children with human immunodeficiency virus infection. J Pediatr 125:142–146
Nadal D, Caduff R, Frey E, Hassam S, Zimmermann DR, Seigneurin JM, Plüss H-J, Seger RA (1994) Non-Hodgkin's lymphoma in four children infected with the human immunodeficiency virus: association with Epstein-Barr virus and treatment. Cancer 73:224–230
Nath A, Hartloper V, Furer M, Fowke KR (1995) Infection of human fetal astrocytes with HIV-1: viral tropism and the role of cell to cell contact in viral transmission. J Neuropathol Exp Neurol 54:320–330
Nozyce M, Hittelman J, Muenz L, Durako SJ, Fischer ML, Willoughby A (1994) Effect of perinatally acquired human imunodeficiency virus infection on neurodevelopment in children during the first two years of life. Paediatrics 94:883–891
Nozyce M, Hoberman M, Arpadi S, Wiznia A, Lambert G, Dobroszycki J, Chang CJ, St Louis Y (1994) A 12-month study of the effects of oral zidovudine on neurodevelopmental functioning in a cohort of vertically HIV-infected inner-city children. AIDS 8:635–639
Ogino MT, Dankner WM, Spector SA (1993) Development and significance of zidovudine resistance in children infected with human immunodeficiency virus. J Pediatr 123:1–8
Papola P, Alvarez M, Cohen HJ (1994) Developmental and service needs of school-age children with human immunodeficiency virus infection: a descriptive study. Paediatrics 94:914–918
Park YD, Belman AL, Kim T-S, Kure K, Llena JF, Lantos G, Bernstein L, Dickson DW (1990) Stroke in paedi atric acquired immunodeficiency syndrome. Ann Neurol 28:303–311
Pavlakis SG, Frank Y, Nocyze M, Porricolo M, Prohovnik I, Wiznia A (1994) Acquired immunodeficiency syndrome and the developing nervous system. Adv Paediat 41:427–451
Pavlakis SG, Lu D, Frank Y, Bakshi S, Pahwa S, Barnett TA, Possicolo ME, Gould RJ, Nozyce ML, Hyman RA (1995) Magnetic resonance spectroscopy in childhood AIDS encephalopathy. Pediatr Neurol 12:277–282
Peckham C, Gibb D (1995) Mother-to-child transmission of the human immunodeficiency virus. N Engl J Med 333:298–302
Petito CK, Roberts B (1995) Evidence of apoptotic cell death in HIV encephalitis. Am J Pathol 146:1121–1130
Philippet P, Blanche S, Sebag G, Rodesch G, Griscelli C, Tardieu M (1994) Stroke and cerebral infarcts in children infected with human immunodeficiency virus. Arch Pediatr Adolesc Med 148:965–970
Pizzo PA, Wilfert CA (1993) Antiretroviral treatment for children with HIV infection. In: Pizzo PA, Wilfert CA (eds) Paediatric AIDS. 2nd edn Williams and Wilkins, Baltimore pp 651–687
Pizzo PA, Wilfert C (1994) Antiretroviral therapy for infection due to human immunodeficiency virus in children. Clin Infect Dis 19:177–196
Pizzo PA, Eddy J, Fallon J, Balis FM, Murphy RF, Moss H, Wolters P, Brouwers P, Jarosinski P, Rubin M, Broder S, Yarchoan R, Brunetti A, Maha M, Nusinoff-Lehrman S, Poplack DG (1988) Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. N Engl J Med 319:889–896
Pizzo PA, Butler K, Balis F, Brouwers E, Hawkins M, Eddy J, Einloth M, Falloon J, Husson R, Jarosinski P, Meer J, Moss H, Poplack DG, Santacroce S, Wiener L, Wolters P (1990) Dideoxycytidine alone and in alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infection. J Pediatr 117:799–808
Price DB, Inglese CM, Jacobs J, Haller JO, Kramer J, Hotson GC, Loh JP, Schlusselberg D, Menez-Bautista R, Rose AL, Fikrig S (1988) Paediatric AIDS. Neuroradiologic and neurodevelopmental findings. Pediatr Radiol 18:445–448
Raphael SA, Price ML, Lischner HW, Griffin JW, Grover WD, Bagasra O (1991) Inflammatory demyelinating polyneuropathy in a child with symptomatic human immunodeficiency virus infection. J Pediatr 118:242–245
Report of a Working Group of the American Academy of Neurology AIDS task force (1991) Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology 41:778–785
Resnick L, Berger JR, Shapshak P, Tourtellotte WE (1988) Early penetration of the blood-brain barrier by HIV. Neurology 38:9–14
Rolfs A, Schuhmacher HC (1990) Early findings in the cerebrospinal fluid of patients with HIV-1 infection of the central nervous system. N Engl J Med 323:418–419
Rottenberg DA, Moeller JR, Strother SC, Sidtis JJ, Navia BA, Dhawan V, Ginos Z, Price RW (1987) The metabolic pathology of the AIDS dementia complex. Ann Neurol 22:700–706
Rowe PM (1995) Something better than zidovudine for children. Lancet 345:511
Saito Y, Sharer LR, Epstein LG, Michaels J, Mintz M, Louder M, Golding K, Cvetkovich TA, Blumberg BM (1994) Overexpression ofnef as a marker for restricted HIV-1 infection of astrocytes in postmortem paediatric central nervous tissues. Neurology 44:474–481
Saito Y, Sharer LR, Dewhurst S, Blumberg BM, Hall CB, Epstein LG (1995) Cellular localization of human herpesvirus-6 in the brains of children with AIDS encephalopathy. J Neurovirol 1:30–39
Schmitt B, Seeger J, Jacobi G (1992) EEG and evoked potentials in HIV-infected children. Clin Electroncephalogr 23:111–117
Schüpbach J, Böni J, Tomasik Z, Jendis J, Seger R, Kind C, The Swiss Neonatal HIV Study Group (1994) Sensitive detection and early prognostic significance of p24 antigen in heat-denatured plasma of human immunodeficiency virus type 1-infected infants. J Infect Dis 170:318–324
Scott GB, Hutto C, Makuch RW, Matrucci MT, O'Connor T, Mitchell CD, Trapido EJ, Parks WP (1990) Survival in children with perinatally acquired human immunodeficiency virus type 1 infection. N Engl J Med 321:1791–1796
Sharer LR, Epstein LG, Cho E-S, Joshi VV, Meyenhofer MF, Rankin LF, Petito CK (1986) Pathologic features of AIDS encephalopathy in children: evidence for LAV/HTLV-III infection of brain. Hum Pathol 17:271–284
Spector SA (1994) Paediatric antiretroviral choices. AIDS 4 [Suppl 3]:S15-S18
Spector SA, Hsia K, Pratt D, Lathey J, McCuthan JA, Alcaraz JE, Atkinson JH, Gulevich S, Wallace M, Grant I, the HIV Neurobehavioral Research Center Group (1993) Virologic markers of human immunodeficiency virus type 1 in cerebrospinal fluid. J Infect Dis 168:68–74
Stover E, Pequegnat W, Huffman L, Garrick NA, Blumenthal S, Eichler A (1990) CNS aspects of HIV-1 infec tion and AIDS in infants and children: a collaborative research agenda. Paediatr AIDS HIV Infect 1:109–120
Tardieu M, Blanche S, Rouzioux C, Veber F, Griscelli C (1987) Atteintes du système nerveux au cours des infections à HIV-1 du nourrisson. Arch Fr Pediatr 44:495–499
Tardieu M, Héry C, Peudenier S, Boespflug O, Montagnier L (1992) Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-to-cell adhesion. Ann Neurol 32:11–17
Tardieu M, Mayaux M-J, Seibel N, Funck-Brentano I, Teglas J-P, Blanche S (1995) Cognitive assessment of school-age children infected with maternally transmitted human immunodeficiency virus type 1. J Pediatr 126:375–379
Tartaglione TA, Collier AC, Coombs RW, Opheim KE, Cummings DK, Mackay SR, Benedetti J, Corey L (1991) Acquired immunodeficiency syndrome. Cerebrospinal fluid findings in patients before and during long-term oral zidovudine therapy. Arch Neurol 48:695–699
The European Collaborative Group (1990) Neurological signs in young children with human immunodefi ciency virus infection. Pediatr Infect Dis 19:402–406
The European Collaborative Study (1994) Natural history of vertically acquired human immunodeficiency virus-1 infection. Paediatrics 94:815–819
Torantore C, Chandra R, Berger JR, Major EO (1994) HIV-1 infection of subcortical astrocytes in the paediatric central nervous system. Neurology 44:481–487
Tovo PA, Martino M de, Gabiano C, Cappello N, D'Elia R, Loy A, Plebani A, Zuccotti GV, Dallacasa P, Ferraris G, Caselli D, Fundarò C, D'Argenio P, Galli L, Principi N, Stegagno M, Ruga E, Palomba E, The Italian Register for HIV Infection in Children (1992) Prognostic factors and survival in children with perinatal HIV-1 infection. Lancet 339:1249–1253
Tudor-Williams G, St. Clair MH, McKinney RE, Malta M, Walter E, Santacroce S, Mintz M, O'Donnell K, Rudoll T, Vavro CL, Connor EM, Wilfert CM (1992) HIV-1 sensitivity to zidovudine and clinical outcome in children. Lancet 339:15–19
Ultmann MH, Belman AL, Ruff HA, Novick BE, Cone-Wesson B, Cohen HJ, Rubinstein A (1985) Develop mental abnormalities in infants and children with acquired immune deficiency syndrome (AIDS) and AIDS-related complex. Dev Med Child Neurol 27:563–571
Vandersteenhoven JJ, Dbaibo G, Boyko OB, Hulette CM, Anthony DC, Kenny JF, Wilfert CM (1992) Progressive multifocal leukoencephalopathy in paediatric acquired immunodeficiency syndrome. Pediatr Infect Dis J 11:232–237
Vazeux R, Lacroix-Ciaudo C, Blanche S, Cumont M-C, Henin D, Gray F, Boccon-Gibod L, Tardieu M (1992) Low levels of human immunodeficiency virus replication in the brain tissue of children with severe acquired immunodeficiency syndrome encephalopathy. Am J Pathol 140:137–144
Vigliano P, Rigardetto R, Capizzi G, Arfelli P, Barbicinti I, Boffi P, Bonassi E, Cavallo P, Crosa P, Gandione M, Genta M, Morf K, Di Cagno L (1994) EEG diagnostic and predictive value on HIV infection in children. Neurophysiol Clin 24:367–379
Wachtel RC, Tepper VJ, Houck D, McGrath CJ, Thompson C (1994) Neurodevelopment in paediatric HIV infection. Clin Pediatr: 416–420
Wolters PL, Brouwers P, Moss HA, Pizzo PA (1994) Adaptive behavior of children with symptomatic HIV infection before and after zidovudine therapy. J Pediatr Psychol 19:47–61
Wolters PL, Brouwers P, Moss HA, Pizzo PA (1995) Differential receptive and expressive language func tioning of children with symptomatic HIV disease and relation to CT scan brain abnormalities. Paediatrics 95:112–119
Wood WP (1992) Children with acquired immune deficiency syndrome. Radiographic features. Invest Radiol 27:964–970
Working Group on Antiretroviral Therapy: National Paediatric HIV Resource Center (1993) Antiretroviral therapy and medical management of the human immunodeficiency virus-infected child. Pediatr Infect Dis J 12:513–522
Yarchoan R, Pluda JM, Perno C-F, Mitsya H, Broder S (1991) Anti-retroviral therapy of human immunodefi ciency virus infection: current strategies and challenges for the future. Blood 78:859–884
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Exhenry, C., Nadal, D. Vertical human immunodeficiency virus-1 infection: Involvement of the central nervous system and treatment. Eur J Pediatr 155, 839–850 (1996). https://doi.org/10.1007/BF02282832
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02282832